Amy Parison
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Amy Parison
Amy Parison is recorded as CFO at Editas Medicine, Inc. (EDIT). Editas Medicine, Inc. reported in an 8-K filed March 20, 2025 that Amy Parison was appointed Senior Vice President, Chief Financial Officer and Treasurer, effective March 28, 2025. The proxy statement of Editas Medicine, Inc. reports total compensation of $821,655 for Amy Parison in fiscal 2025, including a base salary of $394,202.
“In connection with Mr. Lucera's resignation, on March 19, 2025 the Company appointed Amy Parison, Senior Vice President, Finance as Senior Vice President, Chief Financial Officer and Treasurer of the Company, to be effective as of the close of business on March 28, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Editas Medicine, Inc.
Other people whose current roles at this company are on record from its filings.
- Gilmore O'Neill, M.B., M.M.Sc. CEO, Board Member
- James C. Mullen CEO
- Katrine S. Bosley CEO
- Jessica Hopfield Chairman
- Andrew A. F. Hack CFO
- Eric Ek CFO
- Erick J. Lucera CFO
- Vic Myer CTO
- Bernadette Connaughton Board Member
- David Scadden, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Editas Medicine, Inc. (EDIT) | Senior Vice President and Chief Financial Officer | $394,202 | $821,655 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.